Dr Reddy's Laboratories Other Share Holders Equity 2010-2024 | RDY
Dr Reddy's Laboratories other share holders equity from 2010 to 2024. Other share holders equity can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Dr Reddy's Laboratories other share holders equity for the quarter ending September 30, 2024 was $0.156B, a 194.34% increase year-over-year.
- Dr Reddy's Laboratories other share holders equity for 2024 was $0.056B, a 25.33% decline from 2023.
- Dr Reddy's Laboratories other share holders equity for 2023 was $0.075B, a 8.54% decline from 2022.
- Dr Reddy's Laboratories other share holders equity for 2022 was $0.082B, a 35.43% decline from 2021.
Dr Reddy's Laboratories Annual Other Share Holders Equity
(Millions of US $) |
| 2024 |
$56 |
| 2023 |
$75 |
| 2022 |
$82 |
| 2021 |
$127 |
| 2020 |
$31 |
| 2019 |
$43 |
| 2018 |
$62 |
| 2017 |
$117 |
| 2016 |
$81 |
| 2015 |
$74 |
| 2014 |
$56 |
| 2013 |
$114 |
| 2012 |
$80 |
| 2011 |
$92 |
| 2010 |
$81 |
| 2009 |
$53 |
Dr Reddy's Laboratories Quarterly Other Share Holders Equity
(Millions of US $) |
| 2024-09-30 |
$156 |
| 2024-06-30 |
$57 |
| 2024-03-31 |
$56 |
| 2023-12-31 |
$62 |
| 2023-09-30 |
$53 |
| 2023-06-30 |
$71 |
| 2023-03-31 |
$75 |
| 2022-12-31 |
$55 |
| 2022-09-30 |
$41 |
| 2022-06-30 |
$51 |
| 2022-03-31 |
$82 |
| 2021-12-31 |
$88 |
| 2021-09-30 |
$104 |
| 2021-06-30 |
$110 |
| 2021-03-31 |
$127 |
| 2020-12-31 |
$116 |
| 2020-09-30 |
$58 |
| 2020-06-30 |
$41 |
| 2020-03-31 |
$31 |
| 2019-12-31 |
$53 |
| 2019-09-30 |
$46 |
| 2019-06-30 |
$41 |
| 2019-03-31 |
$43 |
| 2018-12-31 |
$41 |
| 2018-09-30 |
$42 |
| 2018-06-30 |
$48 |
| 2018-03-31 |
$62 |
| 2017-12-31 |
$68 |
| 2017-09-30 |
$89 |
| 2017-06-30 |
$97 |
| 2017-03-31 |
$117 |
| 2016-12-31 |
$115 |
| 2016-09-30 |
$101 |
| 2016-06-30 |
$82 |
| 2016-03-31 |
$81 |
| 2015-12-31 |
$97 |
| 2015-09-30 |
$78 |
| 2015-06-30 |
$88 |
| 2015-03-31 |
$74 |
| 2014-12-31 |
$56 |
| 2014-09-30 |
$53 |
| 2014-06-30 |
$56 |
| 2014-03-31 |
$56 |
| 2013-12-31 |
$78 |
| 2013-09-30 |
$60 |
| 2013-06-30 |
$75 |
| 2013-03-31 |
$114 |
| 2012-12-31 |
$100 |
| 2012-09-30 |
$102 |
| 2012-06-30 |
$53 |
| 2012-03-31 |
$80 |
| 2011-12-31 |
$33 |
| 2011-09-30 |
$59 |
| 2011-06-30 |
$98 |
| 2011-03-31 |
$92 |
| 2010-12-31 |
$81 |
| 2010-09-30 |
$75 |
| 2010-06-30 |
$73 |
| 2010-03-31 |
$81 |
| 2009-12-31 |
$62 |
| 2009-09-30 |
$57 |
| 2009-06-30 |
$62 |
| 2009-03-31 |
$53 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$11.853B |
$3.350B |
|
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
|
